In a significant step towards making prescription medications more affordable, the U.S. Food and Drug Administration (F.D.A.) has announced a series of measures aimed at expediting the approval process for biosimilar drugs. These cheaper copycat drugs are designed to mimic the effects of more expensive, brand-name biologic medications, which have...